Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Shilajit and Improved Skin Perfusion

Doses used in studies

mg/day: 250 (median 250, IQR 250–250) — 1 study

Time to effect

Median: 3.3 months · IQR 3.3 months–3.3 months · Range 3.3 months–3.3 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
Supplementation with shilajit for 14 weeks was not associated with any reported adverse effect within this period.
from: Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit S

1 of 1 paper

Skin Transcriptome of Middle-Aged Women Supplemented With Natural Herbo-mineral Shilajit Shows Induction of Microvascular and Extracellular Matrix Mechanisms.
- 2019-06-04
- RCT
- Journal of the American College of Nutrition 38(6)
- - Amitava Das
  - Mohamed S El Masry
  - Surya C Gnyawali
  - Surya C Gnyawali
  - Subhadip Ghatak
  - Kanhaiya Singh
  - Richard Stewart
  - Madeline Lewis
  - Abhijoy Saha
  - Gayle Gordillo
  - Savita Khanna
- PubMed: 31161927
- DOI: 10.1080/07315724.2018.1564088
3 Insights on
- Improved Skin Perfusion
- High evidence
- Rigorous Journal
- Adults
At a higher dose (250 mg bid), shilajit improved skin perfusion when compared to baseline or the placebo.
Effect
Neutral
Effect size
Small
Significant
No
Dose
125 mg bid